Advertising healthcare drugs, devices and services on the web can raise some complicated legal issues. An expert panel will discuss both the Federal Drug Administration (FDA) rules that govern drugs and devices and the state licensure requirements that impact providers. The panel will present some example of problematic advertising and how to avoid legal issues when a company advertises their services or those of another company.
A cornerstone of many Health 2.0 companies is using the web to improve patient outcomes and health. However, there are potential governmental and private payer limitations to incentives that are structured like inducements or kickbacks. An expert panel will provide an overview of the laws and discuss specific situations that have been problematic. The panel will then offer some solutions for mitigating risk and how to address government and payer concerns.
A must for Health 2.0 companies that handle health information or interact with people who could perceive themselves as patients. The expert panel will provide a brief overview of the latest requirements and agency interpretations. The panel will then discuss some actual examples of security and patient privacy breeches on the web and how they were handled. Practical tips on how to avoid security and patient privacy breeches will be discussed.
Jason is the CEO and Co-Founder of Mango Health and uses social game design to manage and improve consumer health. He is here today to share with us a new app used to better manage and compare individual consumer’s well being and health.
mHealthCoach has won so many Health 2.0 Developer Challenges that Aamer’s been asked if that was their main business model. Actually, their real business has been working with pharma companies. Their virtual nurse Flornce and their underlying drug reminder engine have attracted interest from pharma companies and incipient ACOs.
Incubated at Partners’ Center for Connected Health, the Healthrageous Personal Health Improvement Platform helps individuals modify health habits. Mary Beth will show the evidence-based ‘journey map’ for diabetes management and discuss the partnership Healthrageous announced with Boehringer Ingelheim.
Mark’s a high-tech veteran who spotted a niche–getting “old style pharmacy web” into the mobile world. Of course now that they’ve got traction, mscripts is adding applications and patient services for its clients, and dosing and patient adherence are top of that list.
Greg started RxVantage to address the inefficiency in scheduling interactions between drug reps and physician offices. He’ll show us how pharma companies have responded to this opportunity and what that has meant for them and physicians.
For patients, improving medication adherence can both bolster patients’ health as well as revenues. But pharma can’t help realize this objective on its own: adherence is a multi-stakeholder sport. Many of the innovations for adherence improvement are coming from outside of pharma…and sometimes aim to help payers (employers, insurance companies) or others whose incentives are not aligned with those of pharma companies